Company Profile

CND Life Sciences
Company Overview
CND Life Sciences is built on a decade of scientific discovery with a goal of improving health outcomes by developing novel, easily accessible testing for neurodegenerative diseases. CND’s technology uses small skin biopsies and a combination of advanced laboratory techniques and neuroimaging to detect abnormal proteins within cutaneous nerve fibers.
Company History
Since our founding, CND Life Sciences has been on a mission to advance the care of patients who face the potential diagnosis of a neurodegenerative disease. With long careers in research and clinical care, our founders? set out to unlock? deeper stories within the skin by? detecting key pathological markers in the peripheral nervous system that had been previously out of reach.
FAST FACTS
Founded in 2017 as Cutaneous NeuroDiagnostics, LLC
Founders: Todd Levine MD, Christopher Gibbons MD, and Roy Freeman MD
Headquartered in Scottsdale, AZ with a CLIA-certified and CAP-accredited lab
Launched the Syn-One Test® in August 2019
Supported by three (3) NIH-SBIR grants
A Medicare participating provider with reimbursement from national and regional payers
Received accreditation by the College of American Pathologists in June 2023
Research agreements with multiple biopharmaceutical companies
Positions Available
- Viewing 1 - 1 of 1 Jobs